Industrial robots such as aerial drones, ground autonomous robots and explosion-proof robots are steadily being incorporated into industrial plants. Right from carrying out routine plant inspections to entering hazardous zones, industrial robots can do it all.

Shoko has recently announced that the manufacturing plant for the new pharmaceutical excipient “Viscomedi” has been completed in South Korea, and full-scale commercial production also began in February 2026.

Mitsui Chemicals has entered into a MOU with Dangote Industries to establish a comprehensive partnership. With this move, both the firms will jointly explore concrete possibilities to contribute to strengthening the living foundations and developing regional industries in African countries.

With a whooping investment of 4+ billion euros, Project One—Europe’s most sustainable cracker—is the largest investment in the region’s chemical sector in the past 2 decades. The project is expected to produce 1.5 million tonnes of ethylene annually and will have a carbon footprint of less than half of the 10 % best-performing steam crackers in Europe!

Under a project development agreement signed between Sabic and Rongsheng Petrochemical, both the companies will work together to advance the development of the Jintang New Materials Project in Zhoushan, Zhejiang Province, China.

Under a MOU signed between Covestro, Fertiglobe, and MB Energy, all the parties will explore collaboration across the ammonia value chain in Germany and Europe. Fertiglobe will also explore the potential supply of ammonia through an import terminal which will be built and be operated by MB Energy.

Biobtx has plans to develop the Petra project – the world’s first commercial-scale plant that is capable of converting plastic waste directly into renewable aromatics. The project is expected to produce approximately 10,000 tonnes of renewable aromatic oil per year along with 8,000 tonnes of sustainable byproducts.

With an aim to strengthen its position in China, Clariant has recently expanded its pharmaceutical excipients and specialty chemicals facilities at Daya Bay in China.

Evonik has plans to invest approximately 80-million-euros to expand its biotechnology capabilities and strengthen its contract manufacturing services for the company’s drug substance business.

Marl has received the first hydrogen from the Get H2 Nukleus hydrogen project in Lingen, Lower Saxony, Germany. The initial quantities of renewable hydrogen are being produced in accordance with EU rules.